Syndax Pharmaceuticals Falls 16.4% in Premarket Trading; SK hynix Down 5.1%

Syndax Pharmaceuticals dropped 16.4% and SK hynix fell 5.1% in U.S. premarket trading Tuesday as stock-index futures were mixed and technology shares faced pressure. SK hynix declined 5.1% after falling 4.8% in earlier premarket coverage . Investors were awaiting quarterly earnings from major banks as technology shares came under pressure before the U.S. market opened. The update was recorded at 7:16 a.m. ET (11:16 UTC) Tuesday, Oct. 13. Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.